BackSenti Biosciences Overview

Senti Biosciences Current Cash

Track Senti Biosciences's current cash ($8.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$8.94M
↓ 73.57% YoYΔ $-24.87M vs prior year quarter

Peer average

Loading

Senti Biosciences Current Cash History

Loading

Senti Biosciences vs. peers: Current Cash Comparison

Loading

Senti Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Senti Biosciences (SNTI) FAQ

Senti Biosciences posts a current cash of $8.9M as of March 2026. That compares with $34M in the prior-year period — down 73.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Senti Biosciences's current cash was $34M. The latest reading is $8.9M — a 73.6% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Senti Biosciences's financial statement story. At $8.9M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SNTI's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Senti Biosciences's other metric pages and overview cover the third.